BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 6983502)

  • 21. Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study.
    Stuart RK; Braine HG; Lietman PS; Saral R; Fuller DJ
    Am J Med; 1980 Jun; 68(6):876-85. PubMed ID: 6992570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined cefotaxime-amikacin treatment of infectious episodes in acute leukaemia patients with therapeutically-induced bone marrow aplasia (author's transl)].
    Guy H; Chavanet P; Portier H; Kazmierczak A; Cortet P
    Nouv Presse Med; 1981 Feb; 10(8):654-6. PubMed ID: 6259613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiology of infections in neutropenic patients with acute leukemia. Results of two antibiotic combinations.
    Scaglione C; López H; Fernández A; Marcenac F; Garay G; Dupont J; Pavlovsky S
    Medicina (B Aires); 1981; 41 Suppl():29-34. PubMed ID: 6954341
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination of amikacin and ceftazidime as empiric treatment of febrile leukopenic patients affected by solid tumors.
    Gasparini G; Benedetti M; Fassio T; Canobbio L; Figoli F; Galligioni E; Talamini R; Toffoli G; Tumolo S
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):113-20. PubMed ID: 3549581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole.
    Feld R; Rachlis A; Tuffnell PG; Duncan I; Moran L; Pinfold P; DeBoer G
    Arch Intern Med; 1984 May; 144(5):1005-10. PubMed ID: 6712393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Carbenicillin-trimethoprim/sulphamethoxazole or carbenicillin-tobramycin as empirical treatment of infection in granulocytopenic patients. A controlled prospective trial (author's transl)].
    Rafecas FJ; Sanz MA; Balaguer H; Santos M; Besalduch J; Martinez J; Marty ML; Gobernado M
    Sangre (Barc); 1981; 26(3):335-46. PubMed ID: 7027489
    [No Abstract]   [Full Text] [Related]  

  • 27. Empiric therapy of febrile granulocytopenic patients.
    Hopefl AW
    Am J Hosp Pharm; 1979 Feb; 36(2):178-87. PubMed ID: 369364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
    Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J
    Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies.
    Martino P; Venditti M; Petti MC; Mandelli F; Serra P
    Infection; 1985; 13(3):125-9. PubMed ID: 3928495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Empirical antibiotic therapy in febrile neutropenic patients with acute leukemia].
    Yabe H; Nakamura F; Ishikawa T; Nagai K; Nakayama S
    Rinsho Ketsueki; 1989 May; 30(5):644-9. PubMed ID: 2795878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
    Casali A; Ameglio F; Gionfra T; Tonachella R; Paoletti G; Gallo Curcio C
    Chemioterapia; 1987 Dec; 6(6):440-4. PubMed ID: 3325175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
    Walsh TJ; Schimpff SC
    Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia.
    Wilson JM; Guiney DG
    N Engl J Med; 1982 Jan; 306(1):16-20. PubMed ID: 7053467
    [No Abstract]   [Full Text] [Related]  

  • 34. Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
    Del Favero A; Menichetti F; Guerciolini R; Bucaneve G; Baldelli F; Aversa F; Terenzi A; Davis S; Pauluzzi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1126-9. PubMed ID: 2959198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of imipenem therapy for Nocardia actinomycetomas refractory to sulfonamides.
    Ameen M; Arenas R; Vásquez del Mercado E; Fernández R; Torres E; Zacarias R
    J Am Acad Dermatol; 2010 Feb; 62(2):239-46. PubMed ID: 20005007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bacteremia with granulocytopenia--microbiology and empiric antibiotic treatment].
    Hammerstrøm J; Jacobsen T
    Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4370-5. PubMed ID: 9889610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study].
    Sampi K; Hattori M
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1315-20. PubMed ID: 1503486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of febrile granuloycytopenic cancer patients receiving antineoplastic therapy with a combination of carbenicillin, cefazolin and gentamicin.
    Halpern J; Catane R; Sacks T; Fuks Z
    J Med; 1983; 14(3):193-202. PubMed ID: 6580369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
    Klastersky J; Zinner SH; Calandra T; Gaya H; Glauser MP; Meunier F; Rossi M; Schimpff SC; Tattersall M; Viscoli C
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S35-45. PubMed ID: 3280326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.